Status:
COMPLETED
Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)
Lead Sponsor:
Orion Corporation, Orion Pharma
Conditions:
Asthma
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
4+ years
Phase:
NA
Brief Summary
The purpose of this study is to characterise inspiratory flow parameters across 2 Easyhaler® (EH) inhaler versions and Diskus® inhaler in patients with asthma (including children, adults, and the elde...
Eligibility Criteria
Inclusion
- Written informed consent (IC) obtained
- Documented diagnosis of asthma and/or COPD
- Age: 4 years and above
Exclusion
- Any severe chronic respiratory disease other than asthma or COPD
- Acute respiratory infection
- Any medical condition that in the opinion of the investigator would endanger the subject if he/she participates in the study
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT01424137
Start Date
September 1 2011
End Date
November 1 2011
Last Update
February 3 2012
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Lasnamäe Medicum
Tallinn, Estonia, 13619
2
Children's Clinic of Tartu, Allergy Centre
Tartu, Estonia, 51014
3
Tartu University Hospital, Lung Clinic
Tartu, Estonia, 51014
4
Jorvi Hospital HUS
Espoo, Finland, 02740